Accepted for/Published in: Journal of Medical Internet Research
Date Submitted: Apr 6, 2021
Date Accepted: Dec 16, 2021
Patient Influencers: The Next Frontier in Direct-to-Consumer Pharmaceutical Marketing
ABSTRACT
Social media influencers are becoming an increasingly popular strategic communication tactic used across industry verticals like entertainment, fashion, and beauty, to engage directly with consumers. Pharmaceutical companies have also recently entered the social media marketing arena and within the bounds of governmental regulations, found unsuspecting ways to build relationships directly with patients using covert persuasion tactics like social media influencers. Due to consumers’ negative perceptions of pharmaceutical companies, it makes sense that new marketing tactics are being used to establish and improve relationships with consumers. Previous research well documents the ethical dilemmas of direct-to-consumer advertising, and there is recent burgeoning literature on online covert marketing tactics. The academic and medical literatures, however, are behind in regards to social media influencers used in health and medicine. The current paper highlights and defines current terms used in industry practice, but also calls for more investigation and sets forward a research agenda. As consumers spend more time online and patients continue to consult social media for health information, it is important that this new marketing trend does not go unnoticed.
Citation
Request queued. Please wait while the file is being generated. It may take some time.
Copyright
© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.